Second Generation Immunohistochemical Markers: Reflections from Clinical Implementation - Carcinoid Cancer Foundation
Neuroendokrinní nádory Masarykův onkologický ústav Brno
High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors
28. NEUROENDOKRINNÍ NÁDORY » Linkos.cz
Zacíleno na neuroendokrinní nádory - Biologická léčba
NEUROENDOKRINNÍ TUMORY
A co-culture nanofibre scaffold model of neural cell degeneration in relevance to Parkinson's disease | Scientific Reports
Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice | Journal of Neuroscience
Neuroendokrinní nádory - Zdraví.euro.cz
28. NEUROENDOKRINNÍ NÁDORY » Linkos.cz
Acrylamide alters CREB and retinoic acid signalling pathways during differentiation of the human neuroblastoma SH-SY5Y cell line | Scientific Reports
Neuroendokrinní nádory - Zdraví.euro.cz
Neuroendokrinní nádory Masarykův onkologický ústav Brno
28. NEUROENDOKRINNÍ NÁDORY » Linkos.cz
Neuroendokrinní nádory (karcinoidy) » Linkos.cz
Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiation | Scientific Reports
Visualization of trigeminal ganglion sensory neuronal signaling regulated by Cdk5 - ScienceDirect
Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers - Duan - 2016 - Cancer Cytopathology - Wiley Online Library
Fluorescent Biosensor of CDK5 Kinase Activity in Glioblastoma Cell Extracts and Living Cells - Peyressatre - 2020 - Biotechnology Journal - Wiley Online Library
Centrum pro neuroendokrinní nádory Masarykova onkologického ústavu Masarykův onkologický ústav Brno
Tocotrienols protect differentiated SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cytotoxicity by ameliorating dopamine biosynthesis and dopamine receptor D2 gene expression - ScienceDirect
